At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 70 enrolled
Drug / intervention
repetitive transcranial magnetic stimulation (rTMS) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Trial of Transcranial Magnetic Stimulation for Relief of Tinnitus
In Brief
A Phase 2 clinical trial evaluating repetitive transcranial magnetic stimulation (rTMS) and placebo rTMS for Tinnitus. Completed, enrolled 70 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the effectiveness of repetitive transcranial magnetic stimulation (rTMS) for reducing the loudness or severity of chronic tinnitus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTinnitus
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2010
Enrollment StartMar 2011
Primary CompletionDec 2016
TodayJul 2026
First PostedApr 15, 2010
Enrollment StartMar 1, 2011
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 16.2 years ago
Interventions
repetitive transcranial magnetic stimulation (rTMS)device
rTMS involves application of electromagnetic pulses through a coil to the subject's scalp. Some of the electromagnetic energy is transmitted to underlying neural tissue. The goal for this study: 1 Hz rTMS will suppress neural activity responsible for tinnitus perception.
placebo rTMSdevice
placebo rTMS